TABLE 2

Genetic loci associated with forced expiratory volume in 1 s (FEV1) decline in the Lung Health Study-2

SNPChromosomePositionAlleles (coded/ noncoded)Coded allele frequency %SNP effect# Treatment effectSNP × treatment+
β mL·year−1p-valueβ mL·year−1p-valueβ mL·year−1p-value
rs100574735142887378G/C44.3−12.72.8×10−2−19.13.9×10−218.62.4×10−2
rs111720447768703305C/A95.2−29.51.8×10−2−168.34.1×10−686.64.8×10−6
rs1010867982179372G/C43.9−17.65.3×10−3−38.15.3×10−541.13.1×10−6
rs1361249107007283C/T70.124.55.8×10−555.84.1×10−5−42.61.7×10−6
rs11798996811128639945T/C97.8126.13.0×10−6338.04.1×10−6−173.43.2×10−6
rs124336191471679203A/G48.221.42.3×10−434.64.3×10−4−38.72.5×10−6

Given that the overall slope of FEV1 change was negative, for the single nucleotide polymorphism's (SNP) main effect, a positive β estimate indicates less (or a slower) decline and a negative β estimate indicates more (or an accelerated) decline. #: SNP main effect; : treatment main effect (triamcinolone versus placebo); +: SNP–treatment interaction effect.